Sudarshan Sukhani of s2analytics.com told CNBC-TV18, "Elder Pharmaceuticals is at a point where a lot of resistance can come in, so maybe the news flow has already been discounted. If someone is a long term trader then one would be well advised to switch out of Elder Pharma and go into Cipla or Dr Reddys Laboratories which are far better opportunities or even Lupin."
"If someone is a short term trader there is nothing in it, there is a very strong rally already behind it. So in either case I think one should be looking to exit," he said. Also Read: See Q2 better than Q1; US biz growth in 25-30% range: LupinDiscover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
